REG - GlaxoSmithKline PLC - Block listing Interim Review
RNS Number : 9474NGlaxoSmithKline PLC26 May 2020
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
Period of return:
From:
1 November 2019
To:
30 April 2020
Balance of unallotted securities under scheme(s) from previous return:
153,724
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
370,000
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
388,348
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
135,376
Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline 2009 Share Option Plan - Ordinary Shares
Period of return:
From:
1 November 2019
To:
30 April 2020
Balance of unallotted securities under scheme(s) from previous return:
835,095
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
581,004
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
254,091
Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline 2009 Share Option Plan - ADS
Period of return:
From:
1 November 2019
To:
30 April 2020
Balance of unallotted securities under scheme(s) from previous return:
5,391,416
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
698,736
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
4,692,680
Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline plc Share Save Plan 2012
Period of return:
From:
1 November 2019
To:
30 April 2020
Balance of unallotted securities under scheme(s) from previous return:
2,145,812
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
698,407
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
1,447,405
Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDBLRDZGZKGVLGGZM
Recent news on GSK
See all newsREG - GSK PLC - Nucala receives positive CHMP opinion for COPD
AnnouncementREG - GSK PLC - Depemokimab receives positive CHMP opinion
AnnouncementREG - Stock Exch Notice - Admission to Trading - 12/12/2025
AnnouncementREG - GSK PLC - Transaction in Own Shares
AnnouncementREG - GSK PLC - Positive CHMP opinion on Arexvy for all adults 18+
Announcement